No Data
No Data
Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness
BTIG Maintains MDxHealth(MDXH.US) With Buy Rating, Cuts Target Price to $6
MDxHealth SA (MDXH) Q3 2024 Earnings Call Transcript Summary
MDxHealth Is Maintained at Overweight by Piper Sandler
Lake Street Maintains MDxHealth(MDXH.US) With Buy Rating, Maintains Target Price $7
TD Cowen Maintains MDxHealth(MDXH.US) With Buy Rating, Maintains Target Price $7
No Data
No Data